JAMES C BLAIR Insider Trading Transactions
Get free email notifications about insider trading for JAMES C BLAIR.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JAMES C BLAIR. JAMES C BLAIR is 10% Owner in SENOMYX INC ($SNMX) and 10% Owner in INTRALASE CORP ($ILSE) and 10% Owner in Paratek Pharmaceuticals, Inc. ($PRTK) and Director in Paratek Pharmaceuticals, Inc. ($PRTK) and Director in PHARMION CORP ($PHRM) and 10% Owner in SANTARUS INC ($SNTS) and Director in NUVASIVE INC ($NUVA) and 10% Owner in ALIMERA SCIENCES INC ($ALIM) and 10% Owner in Ocera Therapeutics, Inc. ($TZYM) and 10% Owner in Northstar Neuroscience, Inc. ($NSTR) and 10% Owner in ACHILLION PHARMACEUTICALS INC ($ACHN) and 10% Owner in Achaogen Inc ($AKAO) and 10% Owner in Tobira Therapeutics, Inc. ($TBRA) and Director in CADENCE PHARMACEUTICALS INC ($CADX) and 10% Owner in SENORX INC ($SENO) and Director in aTYR PHARMA INC ($LIFE) and 10% Owner in Pernix Sleep, Inc. ($SOMX) and 10% Owner in INTERCELL USA, INC. ($IOMI) and 10% Owner in Vanda Pharmaceuticals Inc. ($VNDA) and 10% Owner in Volcano Corp ($VOLC) and Director in Volcano Corp ($VOLC) and Director in ZOGENIX, INC. ($ZGNX) and 10% Owner in VERACYTE, INC. ($VCYT) and 10% Owner in Orexigen Therapeutics, Inc. ($OREX) and 10% Owner in Dicerna Pharmaceuticals Inc ($DRNA) and 10% Owner in Evoke Pharma Inc ($EVOK) and 10% Owner in Esperion Therapeutics, Inc. ($ESPR) and 10% Owner in TANDEM DIABETES CARE INC ($TNDM) and Director in Clovis Oncology, Inc. ($CLVS) and 10% Owner in REVA Medical, Inc. ($RVA) and 10% Owner in Durata Therapeutics, Inc. ($DRTX).
Latest Insider Trading Transactions of JAMES C BLAIR
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AKAO, ACHN, ALIM, LIFE, CADX, CLVS, DRNA, DRTX, ESPR, EVOK, IOMI, ILSE, NSTR, NUVA, TZYM, OREX, PRTK, SOMX, PHRM, RVA, SNTS, SNMX, SENO, TNDM, TBRA, VNDA, VCYT, VOLC, ZGNX
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 05 2020 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Option Exercise | A | 6.48 | 40,138 | 260,094 | 40,138 | |
Jun 05 2020 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Option Exercise | A | 6.48 | 40,138 | 260,094 | 40,138 | |
Aug 20 2019 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Buy | P | 5.97 | 20,000 | 119,400 | 20,000 | 0 to 20 K |
Aug 20 2019 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Buy | P | 5.70 | 20,000 | 114,000 | 33,439 | 13.4 K to 33.4 K (+148.82 %) |
Aug 20 2019 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Buy | P | 5.97 | 20,000 | 119,400 | 20,000 | 0 to 20 K |
Aug 20 2019 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Buy | P | 5.70 | 20,000 | 114,000 | 33,439 | 13.4 K to 33.4 K (+148.82 %) |
Jun 10 2019 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Option Exercise | A | 14.66 | 28,882 | 423,410 | 28,882 | |
May 10 2019 | LIFE | aTYR PHARMA INC | BLAIR JAMES C | Director | Option Exercise | A | 0.58 | 20,000 | 11,668 | 20,000 | |
Mar 18 2019 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Buy | J | 0.00 | 522 | 0 | 13,439 | 12.9 K to 13.4 K (+4.04 %) |
Mar 18 2019 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Buy | J | 0.00 | 701 | 0 | 10,105 | 9.4 K to 10.1 K (+7.45 %) |
Mar 18 2019 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Sell | J | 0.00 | 10,000 | 0 | 0 | 10 K to 0 (-100.00 %) |
Mar 18 2019 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Sell | S | 27.79 | 17,056 | 473,986 | 0 | 17.1 K to 0 (-100.00 %) |
Feb 05 2019 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Buy | J | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
Feb 05 2019 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Sell | J | 0.00 | 1,000,000 | 0 | 0 | 1000 K to 0 (-100.00 %) |
Feb 05 2019 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Buy | J | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
Feb 05 2019 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Sell | J | 0.00 | 1,000,000 | 0 | 0 | 1000 K to 0 (-100.00 %) |
Oct 15 2018 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Option Exercise | A | 27.92 | 14,770 | 412,378 | 14,770 | |
May 23 2018 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Buy | J | 0.00 | 5,897 | 0 | 12,917 | 7 K to 12.9 K (+84.00 %) |
May 23 2018 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Sell | J | 0.00 | 32,760 | 0 | 0 | 32.8 K to 0 (-100.00 %) |
May 17 2018 | LIFE | aTYR PHARMA INC | BLAIR JAMES C | Director | Option Exercise | A | 1.35 | 20,000 | 27,000 | 20,000 | |
Aug 18 2017 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Buy | J | 0.00 | 6,477 | 0 | 9,404 | 2.9 K to 9.4 K (+221.28 %) |
Aug 18 2017 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Buy | J | 0.00 | 4,835 | 0 | 7,020 | 2.2 K to 7 K (+221.28 %) |
Aug 18 2017 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Sell | J | 0.00 | 92,518 | 0 | 0 | 92.5 K to 0 (-100.00 %) |
Aug 08 2017 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Sell | S | 78.61 | 18,450 | 1,450,355 | 17,056 | 35.5 K to 17.1 K (-51.96 %) |
Jun 27 2017 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Buy | J | 0.00 | 2,869 | 0 | 92,518 | 89.6 K to 92.5 K (+3.20 %) |
Jun 27 2017 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Sell | J | 0.00 | 286,857 | 0 | 1,000,000 | 1.3 M to 1000 K (-22.29 %) |
Jun 12 2017 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Option Exercise | A | 59.56 | 10,000 | 595,600 | 10,000 | |
May 11 2017 | LIFE | aTYR PHARMA INC | BLAIR JAMES C | Director | Option Exercise | A | 3.15 | 20,000 | 63,000 | 20,000 | |
Jun 13 2016 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Option Exercise | A | 15.23 | 10,000 | 152,300 | 10,000 | |
May 26 2016 | LIFE | aTYR PHARMA INC | BLAIR JAMES C | Director | Option Exercise | A | 3.33 | 18,000 | 59,940 | 18,000 | |
Jan 29 2016 | LIFE | aTYR PHARMA INC | BLAIR JAMES C | Director | Option Exercise | A | 6.14 | 19,428 | 119,288 | 19,428 | |
Sep 24 2015 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Sell | J | 0.00 | 794,888 | 0 | 1,286,857 | 2.1 M to 1.3 M (-38.18 %) |
Jul 17 2015 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Buy | J | 0.00 | 2,185 | 0 | 2,185 | 0 to 2.2 K |
Jul 17 2015 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Sell | J | 0.00 | 41,813 | 0 | 0 | 41.8 K to 0 (-100.00 %) |
Jul 10 2015 | LIFE | aTYR PHARMA INC | BLAIR JAMES C | Director | Option Exercise | A | 14.96 | 6,286 | 94,039 | 6,286 | |
Jun 15 2015 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Option Exercise | A | 87.15 | 10,000 | 871,500 | 10,000 | |
Mar 05 2015 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Sell | S | 77.70 | 8,528 | 662,626 | 35,506 | 44 K to 35.5 K (-19.37 %) |
Mar 05 2015 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Sell | J | 0.00 | 500,000 | 0 | 2,081,745 | 2.6 M to 2.1 M (-19.37 %) |
May 22 2014 | ZGNX | ZOGENIX, INC. | BLAIR JAMES C | Director | Option Exercise | A | 1.94 | 50,000 | 97,000 | 50,000 | |
Jun 19 2014 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Option Exercise | A | 44.52 | 12,414 | 552,671 | 12,414 | |
Feb 04 2014 | DRNA | Dicerna Pharmaceut ... | BLAIR JAMES C | 10% Owner | Option Exercise | C | 7.00 | 156 | 1,092 | 156 | |
Feb 04 2014 | DRNA | Dicerna Pharmaceut ... | BLAIR JAMES C | 10% Owner | Option Exercise | C | 7.00 | 156 | 1,092 | 0 | |
Feb 04 2014 | DRNA | Dicerna Pharmaceut ... | BLAIR JAMES C | 10% Owner | Option Exercise | C | 0.00 | 9,469 | 0 | 0 | |
Feb 04 2014 | DRNA | Dicerna Pharmaceut ... | BLAIR JAMES C | 10% Owner | Option Exercise | C | 0.00 | 3,535 | 0 | 0 | |
Feb 04 2014 | DRNA | Dicerna Pharmaceut ... | BLAIR JAMES C | 10% Owner | Option Exercise | C | 7.00 | 21,041 | 147,287 | 21,041 | |
Feb 04 2014 | DRNA | Dicerna Pharmaceut ... | BLAIR JAMES C | 10% Owner | Option Exercise | C | 7.00 | 21,041 | 147,287 | 0 | |
Feb 04 2014 | DRNA | Dicerna Pharmaceut ... | BLAIR JAMES C | 10% Owner | Option Exercise | C | 0.00 | 1,276,243 | 0 | 0 | |
Feb 04 2014 | DRNA | Dicerna Pharmaceut ... | BLAIR JAMES C | 10% Owner | Option Exercise | C | 0.00 | 476,464 | 0 | 0 | |
Feb 04 2014 | DRNA | Dicerna Pharmaceut ... | BLAIR JAMES C | 10% Owner | Buy | C | 0.00 | 13,004 | 0 | 13,004 | 0 to 13 K |
Feb 04 2014 | DRNA | Dicerna Pharmaceut ... | BLAIR JAMES C | 10% Owner | Buy | C | 0.00 | 1,752,707 | 0 | 1,752,707 | 0 to 1.8 M |
Mar 21 2014 | CADX | CADENCE PHARMACEUT ... | BLAIR JAMES C | Director | Option Exercise | D | 7.21 | 25,000 | 180,250 | 0 | |
Mar 21 2014 | CADX | CADENCE PHARMACEUT ... | BLAIR JAMES C | Director | Option Exercise | D | 2.98 | 17,500 | 52,150 | 0 | |
Mar 21 2014 | CADX | CADENCE PHARMACEUT ... | BLAIR JAMES C | Director | Option Exercise | D | 9.25 | 12,500 | 115,625 | 0 | |
Mar 21 2014 | CADX | CADENCE PHARMACEUT ... | BLAIR JAMES C | Director | Option Exercise | D | 7.16 | 12,500 | 89,500 | 0 | |
Mar 21 2014 | CADX | CADENCE PHARMACEUT ... | BLAIR JAMES C | Director | Option Exercise | D | 9.37 | 12,500 | 117,125 | 0 | |
Mar 21 2014 | CADX | CADENCE PHARMACEUT ... | BLAIR JAMES C | Director | Option Exercise | D | 6.35 | 12,500 | 79,375 | 0 | |
Mar 21 2014 | CADX | CADENCE PHARMACEUT ... | BLAIR JAMES C | Director | Option Exercise | D | 12.30 | 12,500 | 153,750 | 0 | |
Mar 21 2014 | CADX | CADENCE PHARMACEUT ... | BLAIR JAMES C | Director | Sell | D | 14.00 | 27,500 | 385,000 | 0 | 27.5 K to 0 (-100.00 %) |
Mar 21 2014 | CADX | CADENCE PHARMACEUT ... | BLAIR JAMES C | Director | Sell | D | 14.00 | 78,369 | 1,097,166 | 0 | 78.4 K to 0 (-100.00 %) |
Mar 21 2014 | CADX | CADENCE PHARMACEUT ... | BLAIR JAMES C | Director | Sell | D | 14.00 | 7,313,241 | 102,385,374 | 0 | 7.3 M to 0 (-100.00 %) |
Mar 21 2014 | CADX | CADENCE PHARMACEUT ... | BLAIR JAMES C | Director | Sell | D | 14.00 | 50,743 | 710,402 | 0 | 50.7 K to 0 (-100.00 %) |
Mar 21 2014 | CADX | CADENCE PHARMACEUT ... | BLAIR JAMES C | Director | Sell | D | 14.00 | 2,972,678 | 41,617,492 | 0 | 3 M to 0 (-100.00 %) |
Mar 17 2014 | AKAO | Achaogen Inc | BLAIR JAMES C | 10% Owner | Option Exercise | C | 0.00 | 7,430 | 0 | 0 | |
Mar 17 2014 | AKAO | Achaogen Inc | BLAIR JAMES C | 10% Owner | Option Exercise | C | 0.00 | 15,799 | 0 | 0 | |
Mar 17 2014 | AKAO | Achaogen Inc | BLAIR JAMES C | 10% Owner | Option Exercise | C | 0.00 | 10,661 | 0 | 0 | |
Mar 17 2014 | AKAO | Achaogen Inc | BLAIR JAMES C | 10% Owner | Option Exercise | C | 0.00 | 435,663 | 0 | 0 | |
Mar 17 2014 | AKAO | Achaogen Inc | BLAIR JAMES C | 10% Owner | Option Exercise | C | 0.00 | 926,321 | 0 | 0 | |
Mar 17 2014 | AKAO | Achaogen Inc | BLAIR JAMES C | 10% Owner | Option Exercise | C | 0.00 | 625,065 | 0 | 0 | |
Mar 17 2014 | AKAO | Achaogen Inc | BLAIR JAMES C | 10% Owner | Buy | C | 0.00 | 33,890 | 0 | 33,890 | 0 to 33.9 K |
Mar 17 2014 | AKAO | Achaogen Inc | BLAIR JAMES C | 10% Owner | Buy | C | 0.00 | 1,987,049 | 0 | 1,987,049 | 0 to 2 M |
Nov 04 2013 | VCYT | VERACYTE, INC. | BLAIR JAMES C | 10% Owner | Option Exercise | C | 0.00 | 5,053 | 0 | 0 | |
Nov 04 2013 | VCYT | VERACYTE, INC. | BLAIR JAMES C | 10% Owner | Option Exercise | C | 0.00 | 680,972 | 0 | 0 | |
Nov 04 2013 | VCYT | VERACYTE, INC. | BLAIR JAMES C | 10% Owner | Option Exercise | C | 0.00 | 17,677 | 0 | 0 | |
Nov 04 2013 | VCYT | VERACYTE, INC. | BLAIR JAMES C | 10% Owner | Option Exercise | C | 0.00 | 2,382,322 | 0 | 0 | |
Nov 04 2013 | VCYT | VERACYTE, INC. | BLAIR JAMES C | 10% Owner | Buy | C | 0.00 | 22,730 | 0 | 22,730 | 0 to 22.7 K |
Nov 04 2013 | VCYT | VERACYTE, INC. | BLAIR JAMES C | 10% Owner | Buy | C | 0.00 | 3,063,294 | 0 | 3,063,294 | 0 to 3.1 M |
Nov 19 2013 | TNDM | TANDEM DIABETES CA ... | BLAIR JAMES C | 10% Owner | Option Exercise | J | 7.37 | 6,008 | 44,279 | 6,008 | |
Nov 19 2013 | TNDM | TANDEM DIABETES CA ... | BLAIR JAMES C | 10% Owner | Option Exercise | J | 4.40 | 10,068 | 44,299 | 0 | |
Nov 19 2013 | TNDM | TANDEM DIABETES CA ... | BLAIR JAMES C | 10% Owner | Option Exercise | C | 0.00 | 38,941 | 0 | 0 | |
Nov 19 2013 | TNDM | TANDEM DIABETES CA ... | BLAIR JAMES C | 10% Owner | Option Exercise | C | 0.00 | 9,378 | 0 | 0 | |
Nov 19 2013 | TNDM | TANDEM DIABETES CA ... | BLAIR JAMES C | 10% Owner | Option Exercise | C | 0.00 | 6,071 | 0 | 0 | |
Nov 19 2013 | TNDM | TANDEM DIABETES CA ... | BLAIR JAMES C | 10% Owner | Option Exercise | J | 7.37 | 352,351 | 2,596,827 | 352,351 | |
Nov 19 2013 | TNDM | TANDEM DIABETES CA ... | BLAIR JAMES C | 10% Owner | Option Exercise | J | 4.40 | 590,403 | 2,597,773 | 0 | |
Nov 19 2013 | TNDM | TANDEM DIABETES CA ... | BLAIR JAMES C | 10% Owner | Option Exercise | C | 0.00 | 2,283,114 | 0 | 0 | |
Nov 19 2013 | TNDM | TANDEM DIABETES CA ... | BLAIR JAMES C | 10% Owner | Option Exercise | C | 0.00 | 549,833 | 0 | 0 | |
Nov 19 2013 | TNDM | TANDEM DIABETES CA ... | BLAIR JAMES C | 10% Owner | Option Exercise | C | 0.00 | 356,111 | 0 | 0 | |
Nov 19 2013 | TNDM | TANDEM DIABETES CA ... | BLAIR JAMES C | 10% Owner | Buy | C | 0.00 | 54,390 | 0 | 54,390 | 0 to 54.4 K |
Nov 19 2013 | TNDM | TANDEM DIABETES CA ... | BLAIR JAMES C | 10% Owner | Buy | C | 0.00 | 3,189,058 | 0 | 3,189,058 | 0 to 3.2 M |
Aug 28 2013 | TBRA | Tobira Therapeutic ... | BLAIR JAMES C | 10% Owner | Option Exercise | C | 0.00 | 7,407 | 0 | 0 | |
Aug 28 2013 | TBRA | Tobira Therapeutic ... | BLAIR JAMES C | 10% Owner | Option Exercise | C | 0.00 | 2,899 | 0 | 0 | |
Aug 28 2013 | TBRA | Tobira Therapeutic ... | BLAIR JAMES C | 10% Owner | Option Exercise | C | 0.00 | 4,233 | 0 | 0 | |
Aug 28 2013 | TBRA | Tobira Therapeutic ... | BLAIR JAMES C | 10% Owner | Option Exercise | C | 0.00 | 225,913 | 0 | 0 | |
Aug 28 2013 | TBRA | Tobira Therapeutic ... | BLAIR JAMES C | 10% Owner | Option Exercise | C | 0.00 | 894,120 | 0 | 0 | |
Aug 28 2013 | TBRA | Tobira Therapeutic ... | BLAIR JAMES C | 10% Owner | Option Exercise | C | 0.00 | 270,568 | 0 | 0 | |
Aug 28 2013 | TBRA | Tobira Therapeutic ... | BLAIR JAMES C | 10% Owner | Option Exercise | C | 0.00 | 394,969 | 0 | 0 | |
Aug 28 2013 | TBRA | Tobira Therapeutic ... | BLAIR JAMES C | 10% Owner | Buy | C | 0.00 | 7,407 | 0 | 14,920 | 7.5 K to 14.9 K (+98.59 %) |
Aug 28 2013 | TBRA | Tobira Therapeutic ... | BLAIR JAMES C | 10% Owner | Buy | C | 0.00 | 2,899 | 0 | 7,513 | 4.6 K to 7.5 K (+62.83 %) |
Aug 28 2013 | TBRA | Tobira Therapeutic ... | BLAIR JAMES C | 10% Owner | Buy | C | 0.00 | 4,233 | 0 | 4,614 | 381 to 4.6 K (+1,111.02 %) |
Aug 28 2013 | TBRA | Tobira Therapeutic ... | BLAIR JAMES C | 10% Owner | Buy | P | 4.00 | 750,000 | 3,000,000 | 2,571,117 | 1.8 M to 2.6 M (+41.18 %) |
Aug 28 2013 | TBRA | Tobira Therapeutic ... | BLAIR JAMES C | 10% Owner | Buy | C | 0.00 | 225,913 | 0 | 1,821,117 | 1.6 M to 1.8 M (+14.16 %) |
Aug 28 2013 | TBRA | Tobira Therapeutic ... | BLAIR JAMES C | 10% Owner | Buy | C | 0.00 | 894,120 | 0 | 1,595,204 | 701.1 K to 1.6 M (+127.53 %) |
Aug 28 2013 | TBRA | Tobira Therapeutic ... | BLAIR JAMES C | 10% Owner | Buy | C | 0.00 | 270,568 | 0 | 701,084 | 430.5 K to 701.1 K (+62.85 %) |
Aug 28 2013 | TBRA | Tobira Therapeutic ... | BLAIR JAMES C | 10% Owner | Buy | C | 0.00 | 394,969 | 0 | 430,516 | 35.5 K to 430.5 K (+1,111.12 %) |
Jul 16 2013 | TZYM | Ocera Therapeutics ... | BLAIR JAMES C | 10% Owner | Buy | P | 6.03 | 331,873 | 1,999,999 | 1,897,336 | 1.6 M to 1.9 M (+21.20 %) |
Jul 16 2013 | TZYM | Ocera Therapeutics ... | BLAIR JAMES C | 10% Owner | Buy | P | 6.03 | 7,333 | 44,192 | 7,333 | 0 to 7.3 K |
Jul 16 2013 | TZYM | Ocera Therapeutics ... | BLAIR JAMES C | 10% Owner | Buy | P | 6.03 | 988,285 | 5,955,801 | 988,285 | 0 to 988.3 K |
Sep 30 2013 | EVOK | Evoke Pharma Inc | BLAIR JAMES C | 10% Owner | Option Exercise | C | 0.00 | 19,006 | 0 | 0 | |
Sep 30 2013 | EVOK | Evoke Pharma Inc | BLAIR JAMES C | 10% Owner | Option Exercise | C | 0.00 | 1,114,327 | 0 | 0 | |
Sep 30 2013 | EVOK | Evoke Pharma Inc | BLAIR JAMES C | 10% Owner | Buy | C | 0.00 | 19,006 | 0 | 19,006 | 0 to 19 K |
Sep 30 2013 | EVOK | Evoke Pharma Inc | BLAIR JAMES C | 10% Owner | Buy | C | 0.00 | 1,114,327 | 0 | 1,114,327 | 0 to 1.1 M |
Jul 02 2013 | ESPR | Esperion Therapeut ... | BLAIR JAMES C | 10% Owner | Option Exercise | J | 6.99 | 1,193 | 8,339 | 1,193 | |
Jul 02 2013 | ESPR | Esperion Therapeut ... | BLAIR JAMES C | 10% Owner | Option Exercise | J | 1.00 | 8,346 | 8,346 | 0 | |
Jul 02 2013 | ESPR | Esperion Therapeut ... | BLAIR JAMES C | 10% Owner | Option Exercise | C | 0.00 | 30,462 | 0 | 0 | |
Jul 02 2013 | ESPR | Esperion Therapeut ... | BLAIR JAMES C | 10% Owner | Option Exercise | J | 6.99 | 70,042 | 489,594 | 70,042 | |
Jul 02 2013 | ESPR | Esperion Therapeut ... | BLAIR JAMES C | 10% Owner | Option Exercise | J | 1.00 | 489,320 | 489,320 | 0 | |
Jul 02 2013 | ESPR | Esperion Therapeut ... | BLAIR JAMES C | 10% Owner | Option Exercise | C | 0.00 | 1,786,012 | 0 | 0 | |
Jul 02 2013 | ESPR | Esperion Therapeut ... | BLAIR JAMES C | 10% Owner | Buy | P | 14.00 | 4,791 | 67,074 | 35,253 | 30.5 K to 35.3 K (+15.73 %) |
Jul 02 2013 | ESPR | Esperion Therapeut ... | BLAIR JAMES C | 10% Owner | Buy | C | 0.00 | 30,462 | 0 | 30,462 | 0 to 30.5 K |
Jul 02 2013 | ESPR | Esperion Therapeut ... | BLAIR JAMES C | 10% Owner | Buy | P | 14.00 | 280,923 | 3,932,922 | 2,066,935 | 1.8 M to 2.1 M (+15.73 %) |
Jul 02 2013 | ESPR | Esperion Therapeut ... | BLAIR JAMES C | 10% Owner | Buy | C | 0.00 | 1,786,012 | 0 | 1,786,012 | 0 to 1.8 M |
Jun 19 2013 | ZGNX | ZOGENIX, INC. | BLAIR JAMES C | Director | Option Exercise | A | 1.50 | 45,000 | 67,500 | 45,000 | |
Jun 14 2013 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Option Exercise | A | 71.11 | 12,414 | 882,760 | 12,414 | |
Jun 13 2013 | CADX | CADENCE PHARMACEUT ... | BLAIR JAMES C | Director | Option Exercise | A | 7.21 | 25,000 | 180,250 | 25,000 | |
Jan 18 2013 | ACHN | ACHILLION PHARMACE ... | BLAIR JAMES C | 10% Owner | Buy | J | 0.00 | 66,462 | 0 | 159,896 | 93.4 K to 159.9 K (+71.13 %) |
Jan 18 2013 | ACHN | ACHILLION PHARMACE ... | BLAIR JAMES C | 10% Owner | Sell | J | 0.00 | 1,000,000 | 0 | 5,772,968 | 6.8 M to 5.8 M (-14.76 %) |
Jul 24 2012 | DRTX | Durata Therapeutic ... | BLAIR JAMES C | 10% Owner | Option Exercise | C | 0.00 | 16,529 | 0 | 0 | |
Jul 24 2012 | DRTX | Durata Therapeutic ... | BLAIR JAMES C | 10% Owner | Option Exercise | C | 0.00 | 2,227,596 | 0 | 0 | |
Jul 24 2012 | DRTX | Durata Therapeutic ... | BLAIR JAMES C | 10% Owner | Buy | P | 9.00 | 5,777 | 51,993 | 22,306 | 16.5 K to 22.3 K (+34.95 %) |
Jul 24 2012 | DRTX | Durata Therapeutic ... | BLAIR JAMES C | 10% Owner | Buy | C | 0.00 | 16,529 | 0 | 16,529 | 0 to 16.5 K |
Jul 24 2012 | DRTX | Durata Therapeutic ... | BLAIR JAMES C | 10% Owner | Buy | P | 9.00 | 778,536 | 7,006,824 | 3,006,132 | 2.2 M to 3 M (+34.95 %) |
Jul 24 2012 | DRTX | Durata Therapeutic ... | BLAIR JAMES C | 10% Owner | Buy | C | 0.00 | 2,227,596 | 0 | 2,227,596 | 0 to 2.2 M |
Jun 08 2012 | ZGNX | ZOGENIX, INC. | BLAIR JAMES C | Director | Option Exercise | A | 1.86 | 35,000 | 65,100 | 35,000 | |
May 01 2012 | ZGNX | ZOGENIX, INC. | BLAIR JAMES C | Director | Option Exercise | A | 1.88 | 50,000 | 94,000 | 50,000 | |
Jun 18 2012 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Option Exercise | A | 19.46 | 12,414 | 241,576 | 12,414 | |
Jun 14 2012 | CADX | CADENCE PHARMACEUT ... | BLAIR JAMES C | Director | Option Exercise | A | 2.98 | 17,500 | 52,150 | 17,500 | |
Jun 04 2012 | ACHN | ACHILLION PHARMACE ... | BLAIR JAMES C | 10% Owner | Buy | J | 0.00 | 93,434 | 0 | 93,434 | 0 to 93.4 K |
Jun 04 2012 | ACHN | ACHILLION PHARMACE ... | BLAIR JAMES C | 10% Owner | Sell | J | 0.00 | 1,200,000 | 0 | 6,772,968 | 8 M to 6.8 M (-15.05 %) |
Mar 27 2012 | RVA | REVA Medical, Inc. | BLAIR JAMES C | 10% Owner | Sell | S | 5.16 | 39,136 | 201,942 | 85,186 | 124.3 K to 85.2 K (-31.48 %) |
Mar 27 2012 | RVA | REVA Medical, Inc. | BLAIR JAMES C | 10% Owner | Sell | S | 5.16 | 1,656,581 | 8,547,958 | 3,606,002 | 5.3 M to 3.6 M (-31.48 %) |
Dec 22 2011 | OREX | Orexigen Therapeut ... | BLAIR JAMES C | 10% Owner | Option Exercise | P | 0.00 | 7,882 | 8 | 7,882 | |
Dec 22 2011 | OREX | Orexigen Therapeut ... | BLAIR JAMES C | 10% Owner | Option Exercise | P | 0.00 | 461,265 | 461 | 461,265 | |
Dec 22 2011 | OREX | Orexigen Therapeut ... | BLAIR JAMES C | 10% Owner | Buy | P | 1.45 | 7,882 | 11,429 | 50,643 | 42.8 K to 50.6 K (+18.43 %) |
Dec 22 2011 | OREX | Orexigen Therapeut ... | BLAIR JAMES C | 10% Owner | Buy | P | 1.45 | 461,265 | 668,834 | 2,967,415 | 2.5 M to 3 M (+18.41 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Option Exercise | C | 0.00 | 43,809 | 0 | 0 | |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Option Exercise | C | 0.00 | 20,240 | 0 | 0 | |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Option Exercise | C | 0.00 | 20,240 | 0 | 0 | |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Option Exercise | C | 0.00 | 2,568,521 | 0 | 0 | |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Option Exercise | C | 0.00 | 1,186,657 | 0 | 0 | |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Option Exercise | C | 0.00 | 1,186,657 | 0 | 0 | |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Buy | P | 13.00 | 15,625 | 203,125 | 51,013 | 35.4 K to 51 K (+44.15 %) |